Phenobarbital NDC 70518-4129

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4129Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4129Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70518-4129-0	70518412900	30 TABLET in 1 BLISTER PACK (70518-4129-0)Marketed from Jul 1, 2024
70518-4129-1	70518412901	30 TABLET in 1 BLISTER PACK (70518-4129-1)Marketed from Jul 7, 2026
70518-4129-2	70518412902	100 POUCH in 1 BOX (70518-4129-2) / 1 TABLET in 1 POUCH (70518-4129-3)Marketed from Sep 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenobarbital
Generic name (nonproprietary): phenobarbital
Active ingredients: Phenobarbital — 32.4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jul 1, 2024
Listing expires: Dec 31, 2027
DEA schedule: CIV
Identifiers: Product ID 70518-4129_5a7eee75-4060-cb76-e063-6294a90a4d5cSPL ID 5a7eee75-4060-cb76-e063-6294a90a4d5cSPL set ID 4e2910f2-173d-4b5c-aad3-44f4ab40d8cbRxCUI 199167UNII YQE403BP4D

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518412900 followed by a unit qualifier and the quantity

Package 70518-4129-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 2, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. Sedative B. Anticonvulsant – For the treatment of generalized and partial seizures.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)